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Summary
A hamster monoclonal antibody (mAb) recognizing an epitope in the Vy1Jy4-Cy4 chain of
the y/8 T cell receptor has been generated. Using this mAb, we have quantitated the occur-
rence of Vyl-bearing y/8 T cells in the developing thymus and in the lymphoid organs and
several epithelia ofadult mice. The Vyl-expressing cells constitute a minor y/8 T cell subpop-
ulation during fetal and early postnatal life, but they constitute a major population of 'Y/8 T
cells in the thymus and in the peripheral lymphoid organs in adult mice. In addition, we found
that Vy1-bearing cells comprise a large proportion (15-60%) of the y/8 T cells present in the
intestinal epithelium (i-IEL) in all strains of mice tested. Vy1+ i-IEL are present in athymic
(nude) mice and in antigen-free mice, demonstrating that they can develop extrathymically and
that their presence in the intestinal epithelium is independent of the antigenic load of the gut.
Our results show that Vyl-bearing lymphocytes account for the largest population of y/8 T
cells in the mouse. This population includes a thymus-dependent component that homes to the
secondary lymphoid organs and a thymus-independent component that constitutes a major
fraction of the y/8 i-IELs.
T lymphocytes bearing the y/8 TCR constitute a minor
T cell subpopulation in the thymus and in the periph-
eral lymphoid organs but are often the major T cell type in
epithelial tissues (1-9) . y/8 T cells comprise several differ-
ent subsets as defined by such distinctive parameters as
TCR repertoire, time of appearance during ontogeny, thy-
mus dependence, and anatomical localization (for review,
see reference 10). The physiological role of y/8 T cells is
still poorly understood, partially because of the lack of
knowledge about y/8 T cell ligands.
A large fraction of y/8 T cell hybridomas expressing a
TCR composed of Vy1 Jy4-Cy4 and V86-C8 chains is
constitutively activated to secrete IL-2 (11) . The role of a
specific interaction involving the TCR in this activation has
been suggested by the ability of mAbs against the TCR-
CD3 complex to inhibit spontaneous IL-2 production and
by the fact that transfection of the Vyl/V86 cDNAs into a
TCR- murine hybridoma confers the phenotype ofconsti-
tutive activation onto the recipient cells (11, 12). In some
cases, the reactivity of Vy1/V86 TCR-expressing hybrido-
mas to purified protein derivative (PPD)' and to the 180-196
amino acid region of the mycobacterial heat shock protein
'Abbreviations used in this paper: AgF, antigen free; DEC, dendritic epider-
mal cells; HSP, heat shock protein; i-IEL, intestinal intraepithelial lym-
phocytes; PPD, purified protein derivative; SPF, specific pathogen free.
(HSP) 60 has been demonstrated (13), although failures to
detect such reactivities have also been reported (14, 15) .
Constitutively activated hybridomas expressing the Vyl/
V86 TCR have been isolated from newborn and adult thy-
mus (11, 14, 16), adult spleen (16), liver (17), skin epider-
mis (18), and from the intestinal epithelium ofweanling mice
(15), suggesting that y/8 T cells expressing the Vyl gene
product are normally present in different lymphoid organs
and epithelia. Nevertheless, neither quantification of Vyl-
bearing y/8 T cells in different tissues nor studies on the
origin of these cells has been performed, mainly because of
the lack of mAbs specifically recognizing this population.
Here we describe a hamster mAb (named 2.11) specific for
the mouse Vyl-Cy4 protein and the studies performed to
analyze these issues. Our results show that Vy1-bearing
lymphocytes account for the largest population of y/8 T
cells in the mouse, including a thymus-dependent compo-
nent that localizes to the secondary lymphoid organs and a
thymus-independent component that comprises a signifi-
cant fraction of the y/8 intestinal intraepithelial lympho-
cytes (i-IEL).
Materials and Methods
Animals. C57BL/6 (B6), BALB/c, DBA/2, and C3H/Hej
(C3H) mice were obtained from The Jackson Laboratory (Bar
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Volume 182 December 1995 1921-1930Harbor, ME) or from Ifha-Credo (L'Arbresle, France). BALB.B10
and BALB.C-3H mice were purchased from Bomholtgard
Breeding and Research Center Ltd. (Bomholtvej, Denmark) and
bred at the MIT facilities. BALB/c specific pathogen-free (SPF)
and antigen-free (AgF) animals were a kind gift ofDr. C. Heusser
(Ciba-Geigy, Basel, Switzerland) . Athymic (nu/nu) and (nu/+) lit-
termates were purchased from The Jackson Laboratory, Charles
River Laboratories, Inc. (Wilmington, MA), and Iffa-Credo. All
other mouse strains were purchased from The Jackson Labora-
tory. Adult Armenian hamsters were obtained from Cytogen
(West Roxbury, MA).
Abs. For complement-mediated killing, we used anti-CD4
(RL.174; reference 19) and anti-CD8 (HO 2.2; 20). Both mAbs
were used as culture supernatants. Other mAbs used were H57-
597, anti-C[3 (21); GK1.5, anti-CD4 (22), 53-6.7, anti-CD8 (23);
RA3.6B2, anti-CD45R/13220 (24);M1/70 anti-Mac-1 (25) 3A10,
anti-8 (2), and 536 anti-Vy5 (26). All of these mAbs were puri-
fied from culture supernatant either by ion exchange chromatog-
raphy on DEAE-cellulose or by affinity chromatography on pro-
tein A-Sepharose (Pharmacia, Uppsala, Sweden) and biotinylated
by standard procedures. Biotin-labeled goat anti-mouse IgM was
purchased from Caltag Laboratories (San Francisco, CA); biotin-
labeled anti-CD5 was from Becton Dickinson & Co. (Mountain
View, CA); and FITC-labeled anti-CD8[3, FITC-labeled anti-
Thyl, biotin-labeled anti-V84, andbiotin-labeled anti-Vy4 were
from PharMingen (San Diego, CA).
Immunofluorescence Staining and Flow Cytometric Analysis.
￿
Cells
(105-106) were incubated in staining buffer (PBS, 3% FCS, 0.1%
NaN3) with the indicatedlabeled Abs for30 min on ice. After two
washes, the cells were incubated with streptavidin-PE (Southern
Biotechnology Associates, Birmingham, AL) for 15 min on ice.
After another two washes, 10,000 viable cells were analyzed using
a FACScan©flow cytometer (Becton Dickinson & Co.). Dead cells
were gated out by theirstaining with propidium iodide.
Cell Purifications and Cultures.
￿
The preparation ofdendritic epi-
dermal cells (DEC) and i-IEL has been previously described in
detail (27, 28). The preparation ofy/8 T cell blasts used to pro-
duce y/8 T cell hybridomas was as follows: Thymus and spleen
cell suspensions were prepared according to standard procedures.
Thymocytes were incubated with biotinylated anti-CD4 and anti-
CD8 mAbs, and splenocytes were incubated with biotinylated
anti-TCR-[3, anti-CD4, anti-CD8, anti-13220, and anti-MAC-1
mAbs for 35 min on ice. After washing the unbound Abs, the
cells were incubated with Tonsyl-activated magnetic beads (Dy-
nal Inc., Great Neck, NY) that had been previously coupled to
streptavidin according to the manufacturer's instructions. The in-
cubation was performed for 60 min at 4°C with a slight rocking
of the tubes. After separation of the beads, unbound cells were
cultured in complete medium (DME supplemented with L-gluta-
mine, sodium pyruvate, [3-ME, nonessential amino acids, penicil-
lin, and streptomycin, plus 10% fetal bovine serum) together with
irradiated (1,000 rad) B6 spleen cells (2 X 106/ml) in thepresence
of 50 lr,g/ml of PPD and 10 U/ml of rIL-2. Alternatively, thy-
mocytes were treated with anti-CD4 and anti-CD8 mAbs and
complement for 45 min at 37°C. CD4-CD8- live cells were pu-
rified by density gradient centrifugation using Lympholyte M
(Cederlane Laboratories, Ltd., Hornby, Ontario, Canada) and
cultured (5 X 105/ml) in complete medium plus 10 U/ml ofrIL-2,
in plates previously coated with the 2.11 mAb (20 Wg/ml).
Production of T Cell Hybridomas.
￿
3-5 d after initiation o£thecul-
tures described above, growing blasts were fused to the TCR-
a/[3- variant ofthe BW5147 thymoma cell line (29) at a 1:1 ratio
in 0.5 ml of 50% polyethylene glycol as described (30) . The cells
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were then distributed in 96-well flat-bottomed plates with either
HAT or azaserine-hypoxanthin medium. The hybridomas named
T and S come from PPD-stimulated thymocytes and splenocytes,
respectively. The hybridomas named BTC come from thymo-
cytes activatedwith the 2.11 mAb.
Production ofthe 2.11 mAb.
￿
Armenian hamsters were immu-
nized intraperitoneally three times at 3-wk intervalswith 2 X 106-
10' irradiated, TCR y/8+ T3 .13.1 hybridoma cells resuspended
in saline. The T3 .13.1 hybridoma expresses a TCR composed of
Vy1 and V86.3 chains and constitutively secretes IL-2 when cul-
tured in vitro. 3 d after the last injection, spleen cells were fused
with the murine myeloma SP2/0 at a ratio of 10:1 (spleen cell/
myeloma) in 1 ml of 50% polyethylene glycol as described (2).
The cells were then distributed in 96-well flat-bottomed plates
with HAT medium. Culture supernatants from growth-positive
wells were tested for their ability to inhibit the constitutive IL-2
production ofthe immunizing hybridoma. IL-2 production wasas-
sayedby thegrowth oftheHT-2 cells, scored by theMTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide) assay
as originally described (31) . Cells from wells inhibiting >75% of
the IL-2 secretion were subcloned several times by limiting dilu-
tion until stable Ab-secreting hybrids were obtained.
Cell Surface Labeling and Immunoprecipitation .
￿
8
￿
X
￿
106 ￿Vyl-
expressing hybridoma cells were harvested by centrifugation,
washed four times with PBS, and resuspended in 4 ml of PBS.
Cells were split into nine glass test tubes coated with Iodogen
(Pierce, Rockford, IL), and 200 p,Ci Na'ZSI was added to each
tube. After a 15-min incubation on ice with occasional mixing,
cells were pooled and washed four times with PBS. The cell pel-
let was lysed in 1.5 ml ice cold lysis buffer (10 mM Tris-HCI, pH
7.6, 150 mM NaCl, 1% Triton X-100, I mM PMSF), vortexed
for 20 s, andincubated on ice for30 min. The lysate was clarified
by centrifugation at 13,000 rpm at 4°C in a microfuge. 0.1 vol of
normal hamsterserum was added to the supernatant, followed by
two rounds of preclearing with 0.1 vol protein A-Sepharose
beads (Pharmacia). One quarter of the precleared lysate was im-
munoprecipitated with 10 Id ofeither 2.11- or 3A10-coated pro-
tein A-Sepharose beads. Immunoprecipitates were washed, resus-
pended in reducing sample buffer, and subjected to SDS-PAGE
on a 10% gel, according to standard procedures. Radioactive
bands were visualized usinga Fujix BAS 2000 Bioimage Analyzer
(Fugi, Fuji Medical Systems USA Inc., Stamford, CT).
PCR and Sequencing Analysis.
￿
The followingprimers were used.
Vy1: 5'-CCGGCAAAAAGCAAAAAAGT-3' ; Jy4: 5'-GCA-
AATATCTTGACCCATGA-3' ; and pan Cy: 5'-CTTATG-
GAGATTTGTTTCAGC-3'.
Genomic DNA from hybridoma cells (T and S) was prepared
by the proteinase K/phenol extraction/ethanol precipitation meth-
od. Sequences spanning the V-J junction were amplified by PCR
using primers specific for the Vy1 andJy4 genes. For each sam-
ple, two PCRs were performed in parallel, each one containing
either one ofthe primers kinased. To produce single-stranded DNA
afterPCR amplification, the double-stranded product was digested
with X exonuclease as originally described (32) . Both strands were
then sequenced by the dideoxy chain termination method using
the Sequenase enzyme (United States Biochemical Corporation,
Cleveland, OH).
Total cellular RNA from hybridoma cells (BTC) was prepared
by the guanidine isothiocyanate/acid phenol extraction method.
cDNA was synthetized with oligo-dT using superscript reverse
transcriptase (GIBCO BRL, Gaithersburg, MD) according to the
manufacturer's instructions. Sequences spanning the V-J junction
were amplified by PCR using primers specific for the Vyl andall
Thymus-dependent and-independent Vyl-bearing 'Y/8 T CellsfourCy genes . After amplification, 4 wl ofeach PCRreaction mix-
ture was incubated with shrimp alkaline phosphatase and exonu-
clease I to remove the excess ofprimers and dNTPsand sequenced
by the dideoxy chain termination method using the Sequenase en-
zyme as described in the Sequenase version 2.0 DNA polymerase
for sequencing PCR products kit (Pharmacia-USB).
Results
Characterization of the 2.11 mAb .
￿
The mAb 2.11 was se-
lected by its ability to block spontaneous IL-2 production by
the Vy1/V86-expressing y/8 T cell hybridoma that had
been used for immunization . Initial studies showed that this
mAb binds to and inhibits spontaneous IL-2 production by
10 of 10 Vyl/V86-expressing T cell hybridomas, but does
not inhibit IL-2 production by ot/R-bearing T cell hybri-
domas (not shown) . Furthermore, the 2 .11 r Ab binds to
the immunizing hybridoma cells but not to variants that have
lost expression ofthe y/8 TCR (not shown), suggesting that
the 2.11 mAb recognizessome component ofthe y/8 TCR .
SDS-PAGE analysis of immunoprecipitates from lysate of
125I-surface-labeled Vy1 hybridoma cells revealed an appar-
ently identical pattern of two bands for the 2.11 mAb and
the pan-y/8-specific mAb, 3A10 (Fig . 1) . This confirms that
the 2.11 mAb is specific for TCR-y/8 .
To characterize further the specificity of the 2.11 mAb,
we stained several y/b T cell hybridomas known to express
different Vy and V8 gene products . The mAb 2.11 did not
bind to previously characterized y/8 T cell hybridomas that
are known to express TCRs containing Vy4, Vy5, Vy6, or
Vy7 chains (30, 33) . In contrast, thismAb recognized 14 of
14 y/8 T cell hybridomas that produce IL-2 spontaneously
(not shown) . Sequence analysis ofrearranged y genes in those
14 hybridomas showed that all contain a functionally rear-
ranged Vy1 gene (Fig . 2 A) . These data demonstrate that
the 2.11 mAb recognizes the Vy1-Cy4 protein but do not
Figure 1 .
￿
2.11 and the pan y/8
specific mAb, 3A10, inununo-
precipitate an identical complex
from surface-labeled VyI-express-
ing hybridoma cells . Lysate from
1211-labeled cells was immunopre-
cipitatedwith2.11 or 3A10 mAbs
and subjected to SDS-PAGE un-
der reducing conditions . 2.11 im-
munoprecipitate (lane 1), 3A10
immunoprecipitate (lane 2) .Mo-
lecular weight markers are indi-
cated in kilodaltons.
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￿
VylJy4junctional sequences of 2.11+ T cell hybridomas .
DNA (A) or cDNA (B) was amplified byPCRwith Vyl-J-y4 or Vyl-Cy
primers, respectively . The products obtained were directly sequenced as
described in Materials and Methods . Hybridomas in A were derived from
adult thymocytes (T) and splenocytes (S) activated in vitro with PPD.
Hybridomas in B were derived from y/b thymocytes activated in vitro
with the 2.11 mAb. P, palindromic nucleotides (54) ; N nucleotides not
present in the germbne sequence .
allow us to exclude the possibility that it also recognizes the
Vy2-Cy2 protein . However, three additional lines of evi-
dence reinforce the conclusion that the 2.11 mAb is spe-
cific for the Vy1-Cy4 protein . (a) 2.11+ hybridomas ob-
tained by fusion of BW5147 cells with CD4-CD8-
thymocytes that had been activated in vitro with the 2 .11
mAb all expressed a functionally rearranged Vy1-Cy4
mRNA (Fig . 2 B), whereas they each expressed one of five
different V8 genes (not shown) . (b) Immunoprecipitation
of the y/8 TCR by the 2 .11 mAb performed with four dif-
ferent y/8 T cell hybridomas showed a 43-kD y chain
compatible with the Vyl chain but incompatible with the
Vy2 chain (1) . (c) Expression of functionally rearranged
Vy1-Cy4 mRNA, but not ofVy2-Cy2 mRNA, correlates
with the 2.11+ phenotype in sorted 2.11+ and 2.11 - y/b T
cell populations (Pereira, P ., D . Gerber, A . Regnault, V .
Hermitte, A . Coutinho, and S . Tonegawa, manuscript sub-
mitted for publication) . Taken together, these data strongly
suggest that the 2.11 mAb recognizes only the product of
the Vyl-Cy4 gene .
Ontogeny of y/S T Cells Expressing the Vyl-Cy4 Gene
Product in the Thymus . Using the 2.11 mAb, we quantitated
the number ofVyl-bearing y/8 thymocytes in B6 mice as
a function of age . For comparison, we also determined the
number ofy/8 thymocytes expressing the Vy4 or the Vy5
chains using the respective antibodies that had previously
been produced (1, 26) . The results are summarized in Fig.
3 . In agreement with previous results (26), Vy5-expressing
thymocytes constituted the major y/8 T cell population at
day 15 of gestation, but their number decreased thereafter
until the first week after birth, when they became nearly
undetectable. Vy4-expressing thymocytes also appeared in
fetal life, and their number increased until 1 wk of age, when
they represented -60% of all y/8 thymocytes . Thereafter,
the number ofVy4+ thymocytes decreased to adult levels
m P N P Jy4
geimline V'yl
geamline Jy4
TGT GCA GTC TGG ATA AA TT
GA TCA GGC ACA
A
T3 .13 .1 TGT GCA GTC TGG TCA GGC ACA
T4 .7 .7 TGT GCA GTC TGG ATA AA GCTC GGC ACA
T3 .23 .2 TGT GCA GTC TGG ATA AA AAGGG GA TCA GGC ACA
53 .11 .2 TGT GCA GTC TGG ATA C CA GGC ACA
T3 .41 .13 TGT GCA GTC TGG ATA GGA GGC ACA
T4 .14 .1 TGT GCA GTC TGG CCCC GA TCA GGC ACA
53 .17 .8 TGT GCA GTC TGG AT GCA A TCA GGC ACA
T4 .36 .6 TGT GCA GTC TGG A CCCCTTC A TCA GGC ACA
T3 .16 .1 TGT GCA GTC TGG AT CC GA TCA GGC ACA
53 .29 .2 TGT GCA GTC TGG A GA TCA GGC ACA
T3 .18 .9 TGT GCA GTC TGG AT CAG A GGC ACA
T3 .20.17 TGT GCA GTC TGG GGG GGC ACA
T4 .41 .6 TGT GCA GTC TGG CCCC GA TCA GGC ACA
T4 .8 .1 TGT GCA GTC TGG CC GA TCA GGC ACA
B
BTC 1 TGT GCA GTC TGG GC A TCA GGC ACA
HTC 7 TGT GCA GTC TGG AT T GGC ACA
BTC 54 TGT GCA GTC -GG AT TA GC ACA
BTC 57 TGT GCA GTC TGG G GA TCA GGC ACA
BTC 58 TGT GCA GTC TGG GTC TCA GGC ACA
BTC 59 TGT GCA GTC TGG AT T TCA GGC ACA
HTC 60 TGT GCA GTC TGG AT GG CA GGC ACA
BTC 63 TGT GCA GTC TGG A AGGGG GGC ACA
BTC 66 TGT GCA GTC TGG ATA AA T TCA GGC ACA
ETC 78 TGT GCA GTC TGG GT A TCA GGC ACAA Thymus
(-45% ofall y/b thymocytes) . Vyl-expressing cells consti-
tuted a very minor population during fetal and early post-
natal life . Their number increased rapidly 1-3 wk after birth,
concomitant with the decrease ofVy4-expressing thymocytes,
and quickly reached the adult levels ofaround one-third of
all y/8 thymocytes (Fig. 3 A) .
In spite of the very low numbers ofVy1-expressing cells
in the fetal thymus, these cells are detectable in the spleen
at birth, constituting -20% of all y/8 T cells in that organ .
Here again, their numbers increased very rapidly, and by 1
wk of age they reached the adult level, which is -40% of
all y/8 splenic T cells in B6 mice (Fig . 3 B) .
Tissue Distribution of Vyl-Cy4-expressing y/S T Cells .
We then quantitated the proportion of Vyl-bearing y/8 T
cells in the peripheral lymphoid organs and in different ep-
ithelia in adult B6, BALB/c, and C3H mice . The results are
summarized in Table 1 . As can be seen, Vyl-bearing cells
represent30-50% of all y/8 T cells in the spleen and lymph
nodes of the three strains studied . Given that Vy4-bearing
cells also represent around half ofthe y/8 T cells in the pe-
ripheral lymphoid organs in these mouse strains (1, 34),
these data show that Vyl- and Vy4-bearing cells comprise
most ofthe spleen and lymph node y/8 T cells .
Table 1 .
￿
Expression ofVyl-Cy4+ y/8TCells in Different
Tissues
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Cells were stained and analyzed as in Fig. 2 . At least three determina-
tions were performed except for DEC, for which the average of two
experiments is given . A pool oftwo to five mice was used for each de-
termination .
B Spleen
Figure 3 . Differential expression of
y/b chains on thymocytes and spleno-
cytes ofC57BL/6 mice ofdifferent ages.
Cells were stained with FITC-labeled
anti-C8 mAb (3A10) and biotin-labeled
anti-Vyl (2 .11), anti-Vy5/Vbl (536),
and anti-Vy4 (UC3-10A6) mAbs fol-
lowed by streptavidin PE . 2,000-5,000
y/8+ cells per sample were analyzed
with a FACScan° . The percentages of
2.11+ (O), 536+ (0), and UC3-l0A6+
(O) cells among 3A10+ cells are shown .
Cell pools were always used for the
analysis, and each point represents the
mean of at least two independent deter-
Days after birth
￿
minations.
Although y/6 T cell clones expressing a TCR composed
of Vy1 and V86 chains have been isolated from the skin
epithelium (18), we found that no more than 2% ofthe y/8-
bearing DEC cells express the Vyl-Cy4 gene product in
any of the three strains examined (B6, BALB/c, and C3H) .
We also found that close to 30% of the -y/8 i-IEL in B6
mice were recognized by the 2.11 mAb and were thus likely
to express the Vyl gene product . This observation was sur-
prising because previous reports analyzing mRNA expres-
sion of Vy genes in i-IEL had led to the belief that Vyl-
bearing cells are at most a small minority of y/8 i-IEL .
Stainings ofB6 i-IEL with the anti-pan y/8 mAb 3A10 to-
gether with either the 2.11 mAb or an anti-V84 mAb are
shown in Fig . 4 . The anti-V84 mAb recognizes a fraction
of the y/8 i-IEL that is mainly included in the Vy7+ popu-
lation (35) . In this particular experiment, the Vyl-bearing
cells represent 28% of the y/8 i-IEL population . It is worth
noting that the level ofTCR expression ofVy1 i-IEL is sig-
nificantly lower than that of other y/8 TCR+ i-IEL (com-
pare gate A in both stainings) . This has been consistently
observed in many individual mice and in all three strains .
We conclude that Vyl+ cells comprise a significant popu-
lation of y/8 i-IEL .
Vyl-Cy4-expressing i-IEL Originate Outside the Thymus .
y/8 i-IEL, as is the case for many ot/R i-IEL, have been
shown to have a thymus-independent origin, as evidenced
by their presence in normal numbers in athymic nude mice
and in thymectomized, lethally irradiated, bone marrow-
reconstituted chimeras (36-38) . Furthermore, thymus-inde-
pendent y/8 cells are phenotypically different from thymus
dependent, peripheral y/8 T cells . Thus, whereas most pe-
ripheral y/8 T cells do not express CD4 or CD8 molecules,
most of the y/8 i-IEL express the ct but not the (3 chain of
the CD8 molecule (39) . Furthermore, although all periph-
eral y/8 T cells express the Thyl and CD5 molecules, only
30-50% ofthe y/8 i-IEL express Thyl, and all o£ them are
negative for the expression of the CD5 antigen (40-42) .
Given the possibility that the Vy1-bearing i-IEL popula-
tion could arise from thymus-dependent peripheral Vyl cells
through migration to the intestinal epithelium, we quanti-
tated the Vyl-expressing cells in i-IEL isolated from athy-
mic nude mice and analyzed the phenotype of Vy1-bearing
Thymus-dependent and -independent Vyl-bearing y/8 T Cells
Tissue
2 .11+
C57BL/6
cells (% of total y/8 T
Strain
BALB/c
cells)
C3H/Hej
Spleen 34.3 ± 5 .3 40.4 ± 3.4 55.4 ± 5.2
LN 38.9±4.4 32.3±6.0 54 -}5.4
i-IEL 24±3 .1 21 .4 -}4.9 36±8.3
DEC 0.7 1.4 1 .6cells in i-IEL preparations isolated from normal animals.
The percentage of y/8 i-IEL marked by the 2 .11 mAb in
normal and nude B6, BALB/c, and C3H mouse strains is
shown in Table 2 . As can be seen, the proportion of Vyl-
bearing cells among y/8 i-IEL was very similar in normal
and nude mice of all strains examined.
The expression ofThyl, CD5, CD8ae, and Cd8(3 among
total y/8 TCR+ or 2.11+ i-IEL in B6 mice is shown in Ta-
ble 3. In concordance with previous observations (39, 41,
42), virtually all the cells stained with the anti-8 mAb were
negative for the expression of CD5 and CD8(3, whereas 80-
90% of them expressed the a chain of the CD8 molecule,
and close to 40% of them expressed the Thyl antigen. The
2 .11+ population displayed a very similar phenotype with
regard to these markers, with most of the cells being CD5 --
CD8a+(3 - . The only significant difference found between
total y/8+ and 2.11 + i-IEL was the proportion of Thyl+
cells (38 and 50%, respectively) . As V-yl+ cells represented
-25% of the total y/8 i-IEL in these experiments, these
data imply that the Thyl antigen is expressed in 50% of the
Vyl + cells and in 20% of the Vy1 - y/8 T cell population.
Normal i-IEL are constitutively cytolytic in a redirected
lysis assay (6, 43). This assay uses an Fc receptor-expressing
target cell and relies on the cross-linking of TCR on effec-
tor cells by mAbs against the TCR-CD3 complex that also
bind to the Fc receptor to trigger lysis. B6 i-IEL lyse P815
target cells in the presence ofthe 2.11 mAb (data not shown),
Table 2.
￿
Expression of Vy1 + i-IEL in Euthymic andAthymic
(nulnu) Mice
2.11+ cells (% of total y/8 T cells)
BALB/c (nu/+)
￿
26.1
BALB/c (nu/nu)
￿
23.4
C57BL/6 (nu/+)
￿
24.5
C57BL/6 (nu/nu)
￿
29.2
C3H (nu/+)
￿
46.1
C3H (nu/nu)
￿
39.8
Cells were stained and analyzed as in Fig. 3. The average oftwo deter-
minations is given. A pool of two to three mice was used for each de-
termination.
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Figure 4.
￿
Expression of Vyl and V64 in i-lEL
from C57BL/6 mice. i-IEL were labeled with
3A10 FITC and either 2.11- or GL4-biotin and
analyzed as described in Materials and Methods.
Gates A and B denote TCR°`° and TCR"O y/b T
cell populations. The fractions of2.11+ and GL-2'
cells among 3A10+ i-IELwere 28 and 24%, respec-
tively.
indicating that the Vy1+ i-IEL population is constitutively
cytolytic.
From these experiments we conclude that, similar to the
V.y7+ i-IEL population, V.yl+ i-IEL also mature extrathy-
mically, and that these y/8 T cell populations are pheno-
typically and functionally similar.
The Proportion of Vy1+ Cells among y/8 i-IEL Is Indepen-
dent of the Antigenic Load of the Intestine. The presence of
Vyl mRNA in the i-IEL population of some individual
mice or in mice infected with the parasite Eimeria has been
reported (44, 45), leading to the suggestion that coloniza-
tion of the gut could result in antigen-driven accumulation
or expansion of a few incipient Vy1 + cells. To study the
effect ofmicrobial colonization and/or food antigens on the
extent of Vyl-bearing cells among y/b i-IEL, we quanti-
tated the proportion of Vy1+ cells in i-IEL isolated from
SPF and AgF BALB/c mice. The results ofone such exper-
iment are shown in Table 4. As can be seen, the proportion
of Vyl-bearing i-IEL was virtually identical in SPF and
AgF BALB/c mice. These experiments demonstrate that
the presence of the Vyl-bearing population in the epithe-
lium of the small intestine is independent of the antigenic
load of the gut epithelium.
Expression of Vyl-Cy4 i-IEL in Different Mouse Strains.
We then quantitated the proportion of Vy1-bearing lym-
phocytes in the i-IEL population of 12 different strains of
mice, including some MHC-congenic strains in different
backgrounds. The results are summarized in Fig. 5 . Several
conclusions can be drawn from this analysis. First, all strains
Table 3.
￿
Phenotypeof Vyi+ i-IEL
Percentage of cells expressing
i-IEL population
￿
Thyl
￿
CD8a
￿
CD8(3
￿
CD5
y/8+ (3A10+)
￿
38.6; 38.0
￿
89.9; 86.6
￿
1.6; 1 .8
￿
<1
Vy1+ (2.11+)
￿
50.8; 50.0
￿
79.0; 81 .9
￿
1.0; 1 .4
￿
<1
C57BL/6 IEL were stained with mAbs against the indicated antigen
and counterstained with either anti-8 (3A10) or anti-Vyl (2.11) mAbs.
Numbers represent the percentage of cells expressing the defined anti-
gen among total ylb cells (upper) or 2.11 + cells (lower). Results from
two independent experiments are shown.Table 4.
￿
Expression of Vyl+ i-IEL in SPFandAgF BALBA
mice
BALB/c SPF
￿
18.1
BALB/c AgF
￿
19.2
Cells were stained and analyzed as in Fig. 3. The average of two deter-
minations is given. Three mice were used for each determination.
tested contained a sizable proportion of Vyl-bearing y/8
i-IEL that ranged from 15 to 60% of all y/8-bearing i-IEL.
Second, the representation of Vyl-bearing lymphocytes
among y/8 i-IEL seems to be strain specific. It should be
pointed out that some of the data presented were obtained
using identical strains of mice that were acquired from dif-
ferent sources and housed in different places. The low stan-
dard deviation observed within a single strain suggests that
genetic rather than environmental factors are responsible
for the observed strain-to-strain differences in the propor-
tion of Vyl-bearing lymphocytes. Third, although differ-
ences in the percentage of y/8 i-IEL expressing the Vy1
gene product are found between MHC-congenic strains,
these differences are relatively small when compared with
those found between strains that differ genetically outside of
the MHC locus. These data suggest that genes other than
MHC genes are involved in the regulation of the number
ofVy1-bearing cells.
Discussion
In this report we describe a new mAb specific for the
Vy1-Cy4 chain of the y/8 TCR. The use of this mAb al-
BALB.B10-b
BALBk-d
BALB.C3H-k
C3H.SW-b
C3H/He3-k
C57BU10-b
B10.D2-d
B10SR-k
C57BIJ6-b
DBA/2-d
B6D2F1-(bxd)
ARR/J-k
Percent oftotal y8 WEL
Figure 5.
￿
Analysis of Vyl usage in inbred mice. i-IEL from the indi-
cated mouse strains were analyzed for 2.11 and 3A10 expression by fluo-
rescence flow cytometry. Data are shown as the percentage of3A10+ cells
that are 2.11+. When standard deviations are shown, at least three deter-
minations were performed; otherwise the mean of two experiments is
given. Two to five mice were used for each determination. In one exper-
iment, five 136 mice were analyzed individually. The small letter after
each strain denotes the MHC haplotype.
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2.11+ Cells (percentage of total
y/8 T cells)
lowed us to quantitate and characterize Vy1-expessing'Y/8
T cells in the thymus offetal and adult animals, as well as in
the peripheral lymphoid organs and in several epithelia.
Our data, while confirming some previously drawn con-
clusions, revealed a few new facts about the composition of
various y/8 T cell subsets in developing and adult mice.
Vyl-bearing cells constitute a small minority of the y/8
thymocytes throughout fetal life. Their number increases
substantially during the first weeks of postnatal life, con-
comitant with a decrease in the number of Vy4-bearing
thymocytes. By 3 wk of age, the Vyl and Vy4 subpopula-
tions reach their adult values of -30 and 50% of the total
y/8 thymocytes, respectively. At that time, Vy5-bearing
cells are virtually absent, and Vy7-bearing thymocytes rep-
resent no more than 5% of total adult y/8 thymocytes (46;
Pereira, P., unpublished observations). Furthermore, al-
though functional rearrangements of Vy6 and Vy2 genes
have been described in the adult thymus (47), it is believed
that y/8 thymocytes expressing these y chains constitute a
small minority amongthe total y/8 thymocytes. Although no
other Vy genes have been identified, a possibility that some
minor populations of y/8 T cells express hitherto unidenti-
fied TCR-y chains cannot be excluded. Taken together,
these data are consistent with the possibility that, at least
in B6 mice, other Vy genes could be expressed in the adult
thymus.
In the spleen and lymph nodes, Vy1- and Vy4-bearing
cells are also the major subpopulations ofthe y/8 T cell pop-
ulation, constituting close to 90% of all y/8 lymphocytes in
these peripheral lymphoid organs. The actual proportion
of Vyl- and Vy4-expressing cells varies in different strains
of mice. Nevertheless, they constitute the large majority of
the splenic and lymph node y/8 T cells in most ofthe com-
mon laboratory strains (34; Pereira, P., unpublished obser-
vations) . Thus, it appears that the proportions ofthe two y/8
T cell subsets are coordinated; a decrease in the frequency
of cells expressing one of these Vy chains is accompanied
by a corresponding increase in the frequency of cells ex-
pressing the other Vy chain. A similar situation can be ob-
served concerning the expression of Vy1 and Vy7 gene
products within the y/8 i-IEL population. Together, Vy1-
and Vy7-bearing cells represent close to 90% of the y/8
i-IEL population, and their relative frequencies in different
strains ofmice are also coordinated (Fig. 5 ; Pereira, P ., un-
published observations). This is particularly important to
consider in the context of positive and/or negative selec-
tion for y/8 T cells. It has been proposed that the expansion
or overrepresentation of T cells using a particular y/8 re-
ceptor could be used as an indication that positive selection
has occurred (34, 38) . Although such increased representa-
tion of a specific y/8 T cell type may suggest that cellular
selection has occurred, the fact that the overrepresentation
of T cells using a defined Vy chain is concomitant to a sim-
ilar underrepresentation of T cells using another Vy chain
precludes definition of the selection as either positive or
negative or both.
Although Vyl-bearing T cells have been isolated from
the skin of C3H mice (18), our data show that Vyl-bear-
Thymus-dependent and -independent Vyl-bearing y/8 T Cellsing cells constitute a minor population (0.5-2%) oftotal y/8
DEC in that strain as well as in the other strains tested. On
the other hand, it has been shown that the skin of nude
mice is colonized by thymus-independent Vyl-bearing y/8
T cells (48), demonstrating that these cells can home to the
epithelium of the skin. Furthermore, recent analysis ofIL-7-
transgenic mice that spontaneously develop dermatitis (49)
has shown a massive infiltration or expansion ofy/8 T cells
other than Vy5-bearing cells in the skin. It is possible, there-
fore, that the representation of Vyl-bearing cells in the
skin epithelium is increased upon infection and could, there-
fore, vary in different mouse colonies.
The most striking finding concerning the tissue localiza-
tion of y/8 T cells expressing the Vy1-Cy4 chain is that they
constitute a substantial proportion of y/8 i-IEL in normal
mice. Vy1 + cells represent 15-60% of all y/8 i-IEL in dif-
ferent strains of mice, and their presence is independent of
the thymus and of the antigenic load of the gut. The fact
that this population has been overlooked is not readily un-
derstood, although some plausible explanations can be put
forward. To date, four different groups have analyzed TCR-y
rearrangement or TCR-y mRNA expression in i-IEL, reach-
ing the conclusion that the Vyl-bearing population is mi-
nor, ifnot absent, in the normal y/8 i-IEL population. The
first group (50) did not analyze Vyl rearrangements in i-IEL
because their previous work (7) had shown that the major
y protein expressed in i-IEL had a relative molecular mass
of 34-35 kD, which is clearly different from the Vyl-Cy4
protein (Mr = 41-42 kD [1]). Besides the fact that the im-
munoprecipitation technique is not very sensitive and is cer-
tainly not quantitative (because of the differential labeling
rates of different proteins and the specificity of the antisera
used), it should also be noted that the size of the Vyl-Cy4
chain is very similar to the size of most of the V8-C8 pro-
teins. Thus, it is possible that the 8 chain band in the gels
masked the Vy1-Cy4 protein.
Two other groups (51, 52) analyzed TCR-y rearrange-
ments in i-IEL by PCR techniques using Vy- and Jy-spe-
cific primers. To analyze Vyl and Vy2 rearrangements, they
used an identical set ofprimers. The Vy-specific primer cross-
hybridizes with Vy1 and Vy2 genes, whereas the Jy-specific
primer cross-hybridizes with all four Jy sequences. A closer
look at the primers used reveals that the Vy primer has a
sequence identical to the Vy2 gene but contains a single
mismatch with respect to the Vyl sequence in the second
base at its 3' end. Similarly, the Jy primer has a sequence iden-
tical to the Jyl and Jy2 segments but has two mismatches
with respect to the Jy4 segment, one of which is located in
the fourth base of its 3' end. The Vy2 gene appears to be
rearranged in almost all y/8 T cells and in many a/[3 T cells
(Pereira, P., D. Gerber, A. Regnault, V. Hermitte, A.
Coutinho, and S. Tonegawa, manuscript submitted for
publication), whereas, with the exception of a small number
ofother y/8 T cells, the Vyl gene is almost exclusively re-
arranged in cells expressing the Vyl-Cy4 protein. Thus, it
seems very likely that, in the PCR conditions used by these
authors, the Vy2Jy2 rearrangements would be preferen-
tially amplified over the VylJy4 rearrangements. Finally,
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the fourth group analyzed the expression of V-y mRNA in
i-IEL by in situ hybridization using antisense probes but
failed to detect any cells expressing either Vyl or Vy2
mRNA (53) . Further experiments conducted by these au-
thors were limited by the preparation o£ cDNAs with a
Cy1-specific primer and subsequent amplification of the
cDNA with primers specific for the Vy4, Vy6, and Vy7
genes, thereby excluding Vy1-Cy4 and Vy2-Cy2 from the
analysis. As this report shows no positive control for the
hybridization ofany ofthe Vy-specific probes, it is possible
that their failure to detect Vyl and Vy2 mRNA simply re-
flects the low sensitivity of the in situ hybridization tech-
nique.
We thus believe that the normal y/8 i-IEL population
contains a relatively high frequency of cells expressing the
Vyl-Cy4 gene product. This frequency is comparable to
the frequency of cells expressing the Vy7-Cy1 chain. The
frequency of the Vyl + i-IEL varies in different strains of
mice but appears to be quite constant among different indi-
viduals of the same strain, even when mice are housed in
different colonies. This suggests that genetic factors, rather
than environmental factors, are primarily responsible for
the determination ofVy1+ i-IEL frequency.
A striking characteristic ofy/8 T cell subsets is the rather
strict correlation among their onset of appearance in devel-
opment, the Vy (and V8) genes used to encode the TCR,
and their homing to distinct peripheral sites. Thus, Vy5-
and Vy6-expressing cells are primarily, if not exclusively,
produced early in the fetal thymus, and home to the epi-
thelium of skin and of uterus, vagina, and tongue, respec-
tively (9, 26, 30, 54-57) . Vy4-bearing cells appear later in
the fetal thymus, constituting the major y/8 thymocyte
population at birth, and preferentially home to the periph-
eral lymphoid organs (1, 2, 33). Vy7-bearing cells, on the
other hand, develop from precursors that do not require a
thymus for maturation and home to the intestinal epithe-
lium (36-38, 50, 51, 53) . Until this study, only a few ex-
ceptions to these rules were observed. Thus, ^2% of the
y/8 thymocytes bear the Vy7 protein (46), and -5% of -1/8
i-IEL express the Vy4 chain in all mouse strains examined,
including athymic mice (Pereira, P., unpublished observa-
tions) . In clear contrast to the other y/6 T cell subsets, the
Vyl-bearing y/8 T cells seem to develop and home in a
more diversified fashion. Thus, they can develop in the thy-
mus and migrate to the peripheral lymphoid organs, where,
together with the Vy4 subset, they represent the vast ma-
jority of the y/8 T cells. On the other hand, Vyl-bearing
cells can also develop extrathymically and constitute, together
with the Vy7 subset, the large majority of y/8 i-IEL. Thus,
the ability to rearrange and express the Vy1 gene is not lim-
ited to a particular y/8 T cell precursor, nor is the differen-
tiation ofVyl-bearing y/8 T cells restricted to a defined mi-
lieu. Thymus-independent Vyl-bearing cells have also been
found in the skin of nude mice (48), and CD8ot+ [3- y/8 T
cells, which are believed to have a thymus-independent or-
igin, have been found in the liver of normal mice (58).
The presence of Vy1-bearing cells in lymphoid organs
and epithelia might be related to their specificity. A largefraction ofVyl cells appears to recognize an endogenous
antigen expressed by lymphocytes (11) . These cells can be
further stimulated in the presence of PPD and HSP pro-
teins or peptides (11, 13), which led to the suggestion that
they might recognize autologous stress proteins (57, 59) . In
some instances, proliferation or accumulation ofVyl-bear-
ing cells has been shown to occur in vivo after infection of
mice with different bacteria or parasites, suggesting a physi-
ological role for those cells in the defense against pathogens
(45, 60, 61) . A similar reactivity has also been described for
a subset of human y/8 T cells that express the Vy9 gene
product. Cells of this type respond to mycobacterial extracts
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(and in some cases to mycobacterial and endogenous HSPs)
and recognize an undefined antigen on the surface of some
tumor cell lines of lymphoid origin (62-70). Cells with
these specificities are restricted in the use of Vy and V8
genes, but there is considerable diversity in the junctional
sequences of their TCR genes (66, 71-74) . As in the case
ofVy1 cells in the mouse, Vy9 cells in humans appear late
in ontogeny, but compose a major y/8T cell population in
adult individuals (75, 76) . This parallelism suggests a precise
and important function of these cells. A precise definition
of the ligands recognized by these cells will certainly help
us to understand their physiological role .
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